综合了关于查家族性高胆固醇血的成本效益的经济证据
Mengying Wang1, Shan Jiang2, Boyang Li3
1School of Management, Shanxi Medical University, Taiyuan, Shanxi, China.
Global health research and policy
|September 26, 2024
概括
家庭性高胆固醇血症 (FH) 查具有成本效益,可以减少健康不平等. 建议实施FH查计划,特别是针对年轻人,以改善人口健康并优化结果.
科学领域:
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
- 遗传学 是一个遗传学.
背景情况:
- 家族性高胆固醇血症 (FH) 是一种常见的遗传疾病,与严重的心血管疾病有关.
- 早期诊断和治疗对于减轻FH后果至关重要.
- 在了解FH查对经济和股权的影响方面存在差距.
研究的目的:
- 综合关于FH查成本效益的经济证据.
- 分析FH查对健康不平等的影响.
主要方法:
- 系统审查FH查的经济评估.
- 综合使用增量成本效益比率 (ICER) 和净健康益处 (NHB) 的成本效益.
- 综合分布式成本效益分析 (DCEA) 以评估健康不平等的影响.
主要成果:
- 在19项包含的研究中,84%发现FH查具有潜在的成本效益.
- 连锁查ICER:$49,630/QALY;全方位查ICER:$20,860/QALY. 这是一个很好的选择.
- DCEA显示增量均等分布的等效健康 (EDEH) 超过了NHB,平均正差为189个QALYs.
结论:
- 查FH通常具有成本效益,并改善了人口健康.
- 查有可能减少健康不平等.
- 政策应支持FH查的实施,特别是在年轻人群中,以优化健康结果和成本效益.
更多相关视频
相关概念视频
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
3
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
3
Cholesterol: Significance and Regulation
519
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
519
Coronary Artery Disease IV: Medical Management
11
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
11
Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
Ultrasound II: Endoscopic Ultrasound and FibroScan
82
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
82


